A detailed history of Norwood Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Norwood Financial Corp holds 3,053 shares of BMY stock, worth $168,769. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,053
Previous 2,603 17.29%
Holding current value
$168,769
Previous $133,000 24.06%
% of portfolio
0.24%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$47.98 - $54.4 $21,591 - $24,480
450 Added 17.29%
3,053 $165,000
Q3 2023

Oct 16, 2023

SELL
$57.89 - $64.73 $5,499 - $6,149
-95 Reduced 3.52%
2,603 $151,000
Q2 2023

Jul 27, 2023

BUY
$63.71 - $70.74 $57,211 - $63,524
898 Added 49.89%
2,698 $172,000
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $96,534 - $112,536
1,800 New
1,800 $112,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Norwood Financial Corp Portfolio

Follow Norwood Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norwood Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Norwood Financial Corp with notifications on news.